Study on the Potential Mechanism of miR-22-5p in Non-Small-Cell Lung Cancer
Disease Markers · 06.09.2022 · 2022 · 1-12
DOI: 10.1155/2022/3750734 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Markers, erschienen am 06.09.2022. Verfasst von Xuemei Han und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Second Hospital of Tianjin Medical University, Tianjin 300211, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, MicroRNAs. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Second Hospital of Tianjin Medical University, Tianjin Municipal Health Commission Science and Technology Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
Non-small-cell lung cancer (NSCLC) ranks among one of the most lethal malignancies worldwide. A better and comprehensive understanding of the mechanism of its malignant progression will be helpful for clinical treating NSCLC.
Methods
The miRNA expression profiles and target gene profiles downloaded from the Gene Expression Omnibus and TargetScan databases were used to identify the key regulatory pattern in NSCLC by bioinformatic analysis. The regulation of miRNA to target mRNA was verified by luciferase reporter assay, quantitative real-time polymerase chain reaction (qRT-PCR), and Western blot. A series of the in vitro and in vivo experiments were conducted to examine the mechanism of the overexpression or knockdown of the miRNA and/or target gene.
Results
In this study, miR-22-5p was remarkably downregulated in NSCLC than in normal lung cells. The in vitro experiments showed that it could substantially inhibit NSCLC cell proliferation, invasion, migration, and epithelial–mesenchymal transition (EMT) progression. The results of luciferase reporter assay, qRT-PCR, and Western blot revealed that TWIST2 was a direct target gene of miR-22-5p. The results of in vitro and in vivo feedback experiments further demonstrated that miR-22-5p relied on TWIST2-induced malignant progression to regulate NSCLC proliferation, metastasis, and EMT progression.
Conclusions
This study revealed that miR-22-5p downregulation contributed to the malignant progression of NSCLC by targeting TWIST2. The findings highlight a potential novel pathway that could be therapeutically targeted in treating NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Second Hospital of Tianjin Medical University, Tianjin 300211, China.
- Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China.
ORCID-Profile: Zhiqiang Zhao
Förderung
- Second Hospital of Tianjin Medical University
- Tianjin Municipal Health Commission Science and Technology Project
- National Natural Science Foundation of China
Zitieren
APA
Han, X., Li, H., Liu, S., & Zhao, Z. (2022). Study on the Potential Mechanism of miR-22-5p in Non-Small-Cell Lung Cancer. Disease Markers, 2022, 1-12. https://doi.org/10.1155/2022/3750734
Vancouver
Han X, Li H, Liu S, Zhao Z. Study on the Potential Mechanism of miR-22-5p in Non-Small-Cell Lung Cancer. Disease Markers. 2022;2022:1-12. doi:10.1155/2022/3750734
BibTeX
@article{Han2022,
author = {Han, Xuemei and Li, Hua and Liu, Shuhui and Zhao, Zhiqiang},
title = {Study on the Potential Mechanism of miR-22-5p in Non-Small-Cell Lung Cancer},
journal = {Disease Markers},
year = {2022},
volume = {2022},
pages = {1--12},
doi = {10.1155/2022/3750734}
}
EUVIMED